Furthermore, it is demonstrated that the C‐terminus (P3) of FBXW2 competitively ablates the function of FBXW2 in KSRP degradation and serves as an effective inhibitor of obesity and atherogenesis progression. The gene discussed is FBXW2; the disease is obesity due to melanocortin 4 receptor deficiency.